Aclaris Therapeutics Reports Second Quarter 2017 Financial Results

Go back to Aclaris Therapeutics Reports Second Quarter 2017 Financial Results
(NASDAQ: ACRS) Delayed: 5.40 --0 (-0%)
Previous Close $5.40    52 Week High $33.88 
Open $5.40    52 Week Low $14.12 
Day High $5.40    P/E N/A 
Day Low $5.40    EPS $0.00 
Volume 117